These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6281998)

  • 1. [The problem of sequential cancers after antineoplastic chemotherapy or radiotherapy].
    Heil G
    Z Gesamte Inn Med; 1982 Feb; 37(3):93-5. PubMed ID: 6281998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nongynecological occult cancers diagnosed in the course of their ovarian metastases. A clinical and anatomicopathological study of 8 cases].
    Favre Y; Genton CY; Ziogas V; Schreiner WE
    Schweiz Med Wochenschr; 1986 Jun; 116(25):845-51. PubMed ID: 3016885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary multiple malignant neoplasms].
    Shkrob OS; Pomelov VS; Kurguzov OP; Grigorian AKh
    Sov Med; 1975 Feb; (2):116-9. PubMed ID: 1145261
    [No Abstract]   [Full Text] [Related]  

  • 4. [Massive cytostatic therapy after orthovoltage therapy].
    Schawow A
    Radiobiol Radiother (Berl); 1970; 11(6):655-9. PubMed ID: 5509232
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary lymphoma of the breast: a clinicopathological study.
    De Padua M; Kaul S; Sarin R; Kaul S; Das PK
    Indian J Pathol Microbiol; 2007 Oct; 50(4):722-5. PubMed ID: 18306536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH
    Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simultaneous and successive neoplastic disease. Apropos of 18 cases of malignant diseases complicating the evolution of Hodgkin's disease].
    Jacquillat C; Belpomme D; Weil M; Auclerc G; Teillet F; Weisgerber C; Tanzer J; Boiron M; Bernard J
    Nouv Presse Med; 1973 Dec; 2(46):3089-92. PubMed ID: 4522824
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a new cytostatic agent (peptichemio) on malignant neoplasms].
    Pittermann E; Stacher A; Griendl W
    Wien Med Wochenschr; 1974 Apr; 124(14):216. PubMed ID: 4522966
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and secondary leukemia.
    Rosner F
    Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).
    Viens P; Palangié T; Janvier M; Fabbro M; Roché H; Delozier T; Labat JP; Linassier C; Audhuy B; Feuilhade F; Costa B; Delva R; Cure H; Rousseau F; Guillot A; Mousseau M; Ferrero JM; Bardou VJ; Jacquemier J; Pouillart P
    Br J Cancer; 1999 Oct; 81(3):449-56. PubMed ID: 10507769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple primary cancers in patients with malignant lymphoma].
    Sakai K; Sueyama H; Saito M; Kitamura T
    Gan No Rinsho; 1984 Sep; 30(12 Suppl):1524-9. PubMed ID: 6513004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant lymphopathy and breast cancer (apropos of 3 cases)].
    Gardais J; Poncheville G
    Sem Hop; 1975 Nov; -51(46):2781-9. PubMed ID: 175447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
    Ben Hassouna J; Slimène M; Boussen H; Bouzaiene H; Khomsi F; Chargui R; Kochbati L; Mtaallah MH; Gamoudi A; Benna F; Hechiche M; Rahal K
    Gynecol Obstet Fertil; 2007 Jun; 35(6):536-40. PubMed ID: 17543568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C; Veraguth A; Lütolf UM
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
    Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K
    J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second malignancies and chemotherapeutic agents.
    Kyle RA
    Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary acute myeloid leukemia early after therapy for Hodgkin's disease--a case report.
    Mihailov G; Ganeva P; Vassileva N; Guenova M; Balacenko G; Toshkov S; Hodjadjik D
    J BUON; 2007; 12(3):403-6. PubMed ID: 17918297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia incidence following primary breast carcinoma treatment.
    Kaplan HG; Malmgren JA; Atwood M
    Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.